MedPath

Comparison of the effect of two regimens of metformin and insulin on results of postpartum glucose tolerance test

Phase 3
Conditions
Gestational Diabetes.
Gestational diabetes mellitus
Registration Number
IRCT20180103038196N5
Lead Sponsor
Gorgan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

Single pregnancy pregnancy
Gestational age 20 to 34 weeks
Diet and exercise treatment for at least a week without blood glucose control
absence of risk factors for lactic acidosis and the absence of anatomical and chromosomal abnormalities
fasting blood sugar greater than or equal to 126 mg / dl , HbA1C levels greater than 6.5%

Exclusion Criteria

Diagnosis of pre-pregnancy diabetes, presence of metabolic disorders in the patient
Need to start treatment with insulin in oral treatment patients
The lower limit of fasting glucose is 92 mg / dL and glucose levels will start for insulin patients two hours after meals, if treatment with metformin is higher than 120.
Dissatisfied to cooperate in the study
metabolic disorder in the patient

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Control of serum glucose level in pregnant women with gestational diabetes mellitus. Timepoint: 4 days and 6 weeks after delivery. Method of measurement: Oral Glucose Tolerance Test and HbA1C Test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath